Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2001
05/16/2001EP1098659A2 Libraries of polyhydroxamates and their analogs
05/16/2001EP1098655A2 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers
05/16/2001EP1098650A1 Benzoquinolizidine and benzoindolizidine derivatives and therapeutic uses thereof
05/16/2001EP1098642A1 Methods for treating conditions modulated by lactosylceramide
05/16/2001EP1098637A1 Transdermal patch and topical compositions comprising propylnorapomorphine
05/16/2001EP1011647A4 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith
05/16/2001EP0941089B1 Use of anti-microtubule agents for treating or preventing multiple sclerosis
05/16/2001EP0859766B1 Chiral methyl phenyl oxazolidinones
05/16/2001EP0839136B1 BENZO[g]QUINOLINE DERIVATIVES
05/16/2001CN1295612A Mutant herpes simplex viruses and uses thereoe
05/16/2001CN1295563A 2-arylethyl-(piperidin-4-ylmethyl) amine derivatives as muscarinic receptor antagonists
05/16/2001CN1295558A Novel local anesthetic compounds and uses
05/16/2001CN1295479A Beta 2-adrenergic receptor agonist
05/16/2001CN1295478A Novel galanic formulation of meloxicam for oral administration
05/16/2001CN1295473A Use of dexmedetomidine for ICU sedation
05/16/2001CN1295471A Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders
05/16/2001CN1295470A Transdermal terapeutic system which contains D2 agonist and which is provided for treating parkinsonism, and method for production thereof
05/16/2001CN1295464A Solid, quick dissolving cetirizine fomulation
05/16/2001CN1295463A Fizzy formulation
05/16/2001CN1295072A New polycyclic system compound as neurotransmitter release reinforcer in treatment of identification fault and derivatives thereof
05/16/2001CN1295065A Phenyl heterocyclic compound used as epoxy enzyme -2 inhibitor
05/16/2001CN1294928A Sobering-up tea and its making process
05/16/2001CN1294918A Drug refraining medicine and its proportioning method
05/16/2001CN1294913A Pharmaceutical use of compound
05/16/2001CN1294911A Substituted nitrobenzene derivative for medicine and other use
05/16/2001CN1065861C Phenyl substituted alkenocarboxylic guanidine, preparation method application as medicine or diagnostic agent and medicine containing it
05/16/2001CN1065768C Methods of treatment of motor neuron cliseases using members of BDNF/NT-3/NGF family of molecule
05/16/2001CN1065763C Dizziness-stopping analgesic
05/15/2001US6232459 Synaptojanin isoform
05/15/2001US6232449 Persephin and related growth factors
05/15/2001US6232350 Administering triphenylethylene antiestrogens (tamoxifen and derivatives-neuroprotectants) to act as cell-nucleus receptor blockers
05/15/2001US6232345 Cerebral function improving agents
05/15/2001US6232329 Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles
05/15/2001US6232321 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
05/15/2001US6232319 Substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them
05/15/2001US6232315 Method for treating inflammatory diseases by administering a thrombin inhibitor
05/15/2001US6232314 Arylalkylpiperazine compounds as antioxidants
05/15/2001US6232313 Pyridazino quinoline compounds
05/15/2001US6232305 Substituted amino bicyclic-β-lactam penam and cepham derivatives as cysteine protease inhibitors
05/15/2001US6232294 Glycosyl vitamin p and trehalose; nervous system, sleep, eating, psychological, and gastrointestinal disorders
05/15/2001US6232286 Methods of stimulating mitogenesis in glial cells using glial mitogenic factors
05/15/2001US6232118 Nucleic acid encoding a protein of defined amino acid sequence; recombinant cell culture production; diagnosis; probes; treatment of parkinson's disease and other nervous system disorders with reduced side effects; gene therapy
05/15/2001US6232097 Nucleotide sequences coding enzymatic polypeptide; prevent bacterial infection; wound healing agents; for vaccine development
05/15/2001US6232082 Vaccines
05/15/2001US6232077 Genetic engineering and expression; cancer diagnosis
05/15/2001US6231886 Methods of providing sustained treatment with opioids
05/15/2001US6231833 Administering to the mammal for treating serotonin system related disorders an effective amount of 2,7-substituted octahydro-1h-pyrido(1,2-a)pyrazine derivative as ligands for serotonin receptor
05/15/2001US6231594 Method of controlling body temperature while reducing shivering
05/15/2001CA2310845C Treatment of neuromuscular disorders and conditions with different botulinum serotype
05/15/2001CA2180011C Botulinum toxins for treating sweating
05/10/2001WO2001033221A1 Axor35, a g-protein coupled receptor
05/10/2001WO2001032910A2 27 human secreted proteins
05/10/2001WO2001032888A2 Human transferase molecules
05/10/2001WO2001032877A2 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO
05/10/2001WO2001032867A1 Polypeptides with expanded primary signalling motifs
05/10/2001WO2001032866A2 Hybrid adaptor receptors
05/10/2001WO2001032865A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences
05/10/2001WO2001032709A2 Polypeptides with non-natural primary signalling motifs
05/10/2001WO2001032704A1 Choline transporter like (ctl) membrane proteins involved in choline transport
05/10/2001WO2001032690A1 Substituted dipeptides having nos inhibiting activity
05/10/2001WO2001032687A1 10 human secreted proteins
05/10/2001WO2001032680A2 18-nor-steroids as selectively active estrogens
05/10/2001WO2001032677A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies
05/10/2001WO2001032676A1 25 human secreted proteins
05/10/2001WO2001032675A1 32 human secreted proteins
05/10/2001WO2001032674A1 26 human secreted proteins
05/10/2001WO2001032663A2 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same
05/10/2001WO2001032659A1 Isoquinoline and quinazoline derivatives for the treatment of cns disorders
05/10/2001WO2001032656A1 Polymorphic form of a tachykinin receptor antagonist
05/10/2001WO2001032654A2 Novel heterocyclic compounds and their use as medicines
05/10/2001WO2001032653A1 Heterocyclic substituted pyrazolones
05/10/2001WO2001032649A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof
05/10/2001WO2001032647A2 Benz`f!indoles for use in the treatment of 5ht receptor related disorders
05/10/2001WO2001032646A2 Sulfonamide derivatives
05/10/2001WO2001032640A1 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants
05/10/2001WO2001032639A1 Nonpeptide substituted benzothiazepines as vasopressin antagonists
05/10/2001WO2001032634A1 2-cyclohexyl benzimidazole nmda/nr2b antagonists
05/10/2001WO2001032629A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists
05/10/2001WO2001032626A1 Isoquinoline and quinazoline derivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity
05/10/2001WO2001032625A1 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
05/10/2001WO2001032624A1 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
05/10/2001WO2001032622A1 Positive modulators of nicotinic receptor agonists
05/10/2001WO2001032620A1 Positive modulators of nicotinic receptor agonists
05/10/2001WO2001032619A1 Positive modulators of nicotinic receptor agonists
05/10/2001WO2001032618A1 Pyrrole derivatives as phosphodiesterase vii inhibitors
05/10/2001WO2001032615A1 1,4 substituted piperidinyl nmda/nr2b antagonists
05/10/2001WO2001032614A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
05/10/2001WO2001032606A1 Compounds having mif antagonist activity
05/10/2001WO2001032602A1 Diaryl-enynes
05/10/2001WO2001032601A1 Polymorphic forms of sertraline hydrochloride
05/10/2001WO2001032595A1 Method for producing compounds of the valproinic acid
05/10/2001WO2001032264A1 Aryl olefinic azacyclic, and aryl acetylenic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors
05/10/2001WO2001032216A2 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance
05/10/2001WO2001032196A1 Secretin fragments for treating autism
05/10/2001WO2001032183A2 Pharmaceutical compositions comprising oxcarbazepine
05/10/2001WO2001032179A1 8-aza-bicyclo[3.2.1]octane nmda/nr2b antagonists
05/10/2001WO2001032178A1 Use of 3,4-substituted piperidines
05/10/2001WO2001032177A1 2-aza-bicyclo[2.2.2]octane nmda/nr2b antagonists
05/10/2001WO2001032176A1 Beta-carboline derivatives for use as analgesics
05/10/2001WO2001032174A1 2-benzyl and 2-heteroaryl benzimidazole nmda/nr2b antagonists